Balchem Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Balchem Corporation (BCPC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $813.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-07-31
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $813.00K, a 75.88% decline year-over-year.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $4.75M, a 242.51% increase year-over-year.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $2.38M, a 22.60% increase year-over-year.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $621.00K, a 88.44% decline year-over-year.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $7.76M, a 58.37% decline from fiscal 2024.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $18.63M, a 474.85% increase from fiscal 2023.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $3.24M, a 19.46% increase from fiscal 2022.
- Balchem Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $2.71M, a 65.51% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $813.00K 10-Q · filed 2026-07-31 | $5.57M 10-Q · filed 2026-07-31 | $7.94M derived: sum of 3 quarters · filed 2026-07-31 | $8.56M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $4.75M 10-Q · filed 2026-04-30 | $7.13M derived: sum of 2 quarters · filed 2026-04-30 | $7.75M derived: sum of 3 quarters · filed 2026-04-30 | $11.12M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $3.00M derived: sum of 2 quarters · filed 2026-02-20 | $6.37M derived: sum of 3 quarters · filed 2026-07-31 | $7.76M 10-K · filed 2026-02-20 |
| 2025-09-30 | $621.00K 10-Q · filed 2025-10-21 | $3.99M derived: sum of 2 quarters · filed 2026-07-31 | $5.38M 10-Q · filed 2025-10-21 | $7.32M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $3.37M 10-Q · filed 2026-07-31 | $4.76M 10-Q · filed 2026-07-31 | $6.70M derived: sum of 3 quarters · filed 2026-07-31 | $12.07M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $1.39M 10-Q · filed 2026-04-30 | $3.33M derived: sum of 2 quarters · filed 2026-04-30 | $8.70M derived: sum of 3 quarters · filed 2026-04-30 | $9.64M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $7.31M derived: sum of 2 quarters · filed 2026-02-20 | $8.25M derived: sum of 3 quarters · filed 2026-02-20 | $18.63M 10-K · filed 2026-02-20 |
| 2024-09-30 | $5.37M 10-Q · filed 2025-10-21 | $6.32M derived: sum of 2 quarters · filed 2025-10-21 | $16.69M 10-Q · filed 2025-10-21 | $17.65M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $944.00K 10-Q · filed 2025-07-31 | $11.32M 10-Q · filed 2025-07-31 | $12.28M derived: sum of 3 quarters · filed 2026-02-20 | $12.38M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $10.38M 10-Q · filed 2025-04-24 | $11.34M derived: sum of 2 quarters · filed 2026-02-20 | $11.44M derived: sum of 3 quarters · filed 2026-02-20 | $12.04M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $961.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.06M derived: sum of 2 quarters · filed 2026-02-20 | $1.66M derived: sum of 3 quarters · filed 2026-02-20 | $3.24M 10-K · filed 2026-02-20 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-10-25 | $697.00K derived: sum of 2 quarters · filed 2024-10-25 | $2.28M 10-Q · filed 2024-10-25 | $3.03M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $597.00K 10-Q · filed 2024-07-26 | $2.18M 10-Q · filed 2024-07-26 | $2.93M derived: sum of 3 quarters · filed 2025-02-21 | $3.75M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $1.58M 10-Q · filed 2024-05-03 | $2.33M derived: sum of 2 quarters · filed 2025-02-21 | $3.15M derived: sum of 3 quarters · filed 2025-02-21 | $3.64M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $1.56M derived: sum of 2 quarters · filed 2025-02-21 | $2.06M derived: sum of 3 quarters · filed 2025-02-21 | $2.71M 10-K · filed 2025-02-21 |
| 2022-09-30 | $815.00K 10-Q · filed 2023-10-27 | $1.31M derived: sum of 2 quarters · filed 2023-10-27 | $1.96M 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $495.00K 10-Q · filed 2023-07-28 | $1.15M 10-Q · filed 2023-07-28 | ||
| 2022-03-31 | $654.00K 10-Q · filed 2023-04-28 | |||
| 2021-12-31 | $7.87M 10-K · filed 2024-02-16 | |||
| 2020-12-31 | $12.70M 10-K · filed 2023-02-24 | |||
| 2019-12-31 | $6.13M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Solstice Advanced Materials Inc. (SOLS) | United States | $8.905B | 67.02 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |